Clinical cancer research : an official journal of the American Association for Cancer Research

Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.

Clinical cancer research : an official journal of the American Association for Cancer Research

Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR, Kasahara N, Bochner BH

Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patients.

Clinical cancer research : an official journal of the American Association for Cancer Research

Bigbee WL, Grandis JR, Siegfried JM

Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patients.

Clinical cancer research : an official journal of the American Association for Cancer Research

Bigbee WL, Grandis JR, Siegfried JM

The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization.

Clinical cancer research : an official journal of the American Association for Cancer Research

Johns TG, Perera RM, Vernes SC, Vitali AA, Cao DX, Cavenee WK, Scott AM, Furnari FB

Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Fridman JS, Caulder E, Hansbury M, Liu X, Yang G, Wang Q, Lo Y, Zhou BB, Pan M, Thomas SM, Grandis JR, Zhuo J, Yao W, Newton RC, Friedman SM, Scherle PA, Vaddi K

A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Small EJ, Tchekmedyian NS, Rini BI, Fong L, Lowy I, Allison JP

The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization.

Clinical cancer research : an official journal of the American Association for Cancer Research

Johns TG, Perera RM, Vernes SC, Vitali AA, Cao DX, Cavenee WK, Scott AM, Furnari FB

Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Fridman JS, Caulder E, Hansbury M, Liu X, Yang G, Wang Q, Lo Y, Zhou BB, Pan M, Thomas SM, Grandis JR, Zhuo J, Yao W, Newton RC, Friedman SM, Scherle PA, Vaddi K

A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Small EJ, Tchekmedyian NS, Rini BI, Fong L, Lowy I, Allison JP

First study of the safety, tolerability, and pharmacokinetics of CP-724,714 in patients with advanced malignant solid HER2-expressing tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research

Munster PN, Britten CD, Mita M, Gelmon K, Minton SE, Moulder S, Slamon DJ, Guo F, Letrent SP, Denis L, Tolcher AW

Pages